0 item(s) - $0.00
You have no items in your shopping cart.


Pillsbrothers – Your Online Pharmacy

The cold season is approaching and your patients at the office are worried.

The cold season is approaching and your patients at the office are worried. A wheeze and a bad cough sent her to the hospital for about four days last could season. To her she has this feeling that she has not quite gotten back to normal. Since she stopped smoking she has suffered respiratory problems. Therefore, she uses bronchodilator and inhales corticosteroids that you prescribed. She is worried of another COPD exacerbation because each time she gets sick it is really difficult to recover. What can she do to make it less likely to get sick this year?

Studies shows that Azicen taken daily for a year decreases the frequency of COPD exacerbation thus improving the quality of life in a cohort with COPD.

Why azicen? The macrolide antibiotic has anti-inflammatory and immune-modulatory benefits (which is why it is given to patients with cystic fibrosis and bronchiectasis) on top of its antibiotic action. However, studies have been split on the question of whether long-term antibiotics benefit patients with COPD.

You can buy Azicen here on

Enter the current study, which enrolled 1,142 patients with COPD from 12 academic centers across the United States.  To be eligible for the study, all patients either used continuous supplemental oxygen or had suffered a COPD exacerbation in the past year that required systemic steroids, a visit to the ED or hospitalization. Approximately 80 percent were receiving inhaled corticosteroids and/or long-acting bronchodilators. (Patients with prolonged QTc or hearing loss were excluded from the study – as these are known to be adverse effects associated with azithromycin).

Participants were randomly assigned to take either azicen at a 250 mg daily dose or a placebo pill for a year. Those with daily azicen stayed exacerbation-free for a significantly longer time: 266 days prior to first exacerbation versus 174 days for those with placebo. There was no statistically significant difference in mortality.

The daily antibiotic also helped patients’ quality of life, as measured by a commonly used survey which asks about symptoms, activity level and overall comfort. However, taking an antibiotic daily does not come without risk. Therefore, its unless prescribed by the doctor don’t take it daily.

The biggest concern, of course, is increasing microbial resistance.  To investigate this question, each patient had nasopharyngeal swabs taken at study visits. More patients in the azicen group became colonized with bacteria that were resistant to macrolide antibiotics, but this finding didn’t have any clear clinical significance. It remains unknown what this resistance pattern could mean for patients’ families or community.

You can buy Azicen here on

Hearing loss was also a potential issue. More patients taking azicen than placebo experienced a decrement in their hearing over the year.

In an accompanying editorial, Nikolaos M. Siafakis, a pulmonologist who is the president of the European Respiratory Society, balanced these risks and benefits, and wrote that the study data come out in favor of azicen: “The findings of Albert and co-workers…in my opinion turns the balance towards the benefits of azithromycin treatment. However, if azicen is going to be used in patients known to be frequent COPD exacerbators, then the local antibiotic resistance patterns should be closely monitored…On balance however the long-term use of azicen to prevent AECOPD seems to be a risk in accord with the classical advice of Hippocrates – do good – no harm.”


You can buy Azicen here on


Leave a Reply

Sorry, you must be logged in to post a comment.